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In HeLa cells, RNA polymerase II mediated transcription is severely inhibited by poliovirus infection. Both basal and
activated transcription are affected to bring about a complete shutoff of host cell transcription. We demonstrate here that
the octamer binding transcription factor, Oct-1, is cleaved in HeLa cells infected with poliovirus. Incubation of Oct-1 with
the purified, recombinant 3Cpro results in the generation of the cleaved Oct-1 product seen in virus infected cells. Poliovirus
infection leads to the formation of altered Oct-1–DNA complexes that can also be generated by incubation of Oct-1 with
purified 3Cpro. We also show that Oct-1 cleaved by 3Cpro loses its ability to inhibit transcriptional activation by the SV40 B
enhancer. These results suggest that cleavage of Oct-1 in poliovirus infected cells leads to the loss of its activity. q 1997
Academic Press
INTRODUCTION binds to the octamer sequence ATGCAAAT (Rosales et
al., 1987; Sturm et al., 1988). Oct-1 regulates the expres-
Infection of mammalian cells with poliovirus leads to sion of some ubiquitously expressed genes such as his-
dramatic inhibition of all three classes of host cell RNA tone H2B and small nuclear RNA (snRNA) genes (Harvey
polymerase known as host cell transcription shutoff et al., 1982; La Bella et al., 1988). U1 and U2 snRNA
(Apriletti and Penhoet, 1978). The RNA polymerases genes encode short nonpolyadenylated RNAs that are
themselves are not affected by poliovirus infection involved in pre-mRNA splicing. These genes are heavily
(Schwartz et al., 1974; Crawford et al., 1981). Transcrip- transcribed by RNA polymerase II (Frederiken et al., 1978;
tional inhibition seen in virus-infected cells appears to Murphy et al., 1982). SnRNA promoters are unusual in
be due to the inactivation of specific transcription factors that they lack a TATA-box but contain a proximal se-
(Clark and Dasgupta, 1990; Clark et al., 1991, 1993; quence element (PSE) that acts as a promoter (Skuzeski
Kliewer and Dasgupta, 1988; Rubinstein et al., 1992). et al., 1984; Ares et al., 1985; Ciliberto et al., 1985; Mattaj
RNA polymerase II requires transcription factors for et al., 1985; Mangin et al., 1986; Murphy et al., 1987;
accurate initiation of transcription. To date, at least seven Hernandez and Lucito, 1988). Oct-1 can activate tran-
RNA polymerase II transcription factors have been identi- scription from the initiation complex assembled at the
fied. They are TFII A, B, D, E, F, H, and J (Dynan and PSE element but cannot activate transcription from the
Tjian, 1985; Reinberg et al., 1987; Reinberg and Roeder, initiation complex at the TATA-box (Tanaka et al., 1988).
1987; Carmaco et al., 1989; Peterson et al., 1991; Flores Oct-1 belongs to a family of homeodomain proteins. It
et al., 1992; Cortes et al., 1992). Transcription factor TFIID is 766 amino acids long and the homeodomain extends
nucleates the formation of the preinitiation complex at from amino acids 280 to amino acid 440 (Fig. 1) (Sturm
the TATA-box. TFIID is a multiprotein complex consisting et al., 1988). It is a bipartite DNA binding structure and
of TATA binding protein (TBP) and TATA binding protein has a helix–turn–helix motif (Sturm and Herr, 1988). On
associated factors (TAFs). Binding of TFIID to the TATA- either side of the homeodomain are the N-terminal and
box followed by other transcription factors and RNA poly- C-terminal regions of Oct-1. The N-terminus of Oct-1 is
merase II results in the formation of the preinitiation com- the transcriptional activation domain for snRNA promot-
plex required for basal transcription of the pol II genes. ers and this region is rich in glutamine residues (Tanaka
Genes transcribed by RNA polymerase II have a pro- et al., 1992). Truncated Oct-1 with an N-terminus deletion
moter element and several upstream regulatory ele- can no longer activate small nuclear RNA transcription.
ments. Activators bind to upstream regulatory elements The B-element of SV40 enhancer has a 7 of 8 bp match
and increase the level of transcription from target genes to the octamer consensus sequence formed by the junc-
(activated transcription). Oct-1 is one such activator that tion of the two Sph motifs (Fig. 6A) (Tanaka et al., 1988).
When present upstream of snRNA promoters, the SV40
octamer motif is a ubiquitous enhancer element,1 To whom correspondence and reprint requests should be ad-
dressed. whereas in the context of an RNA polymerase II mRNA
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encoding promoter such as immunoglobulin genes or b- Purification of Oct-1 from mock- and
poliovirus-infected cell extractsglobin promoter, it is lymphoid specific. In HeLa cells the
octamer motif is inactive and the Sph motifs (Fig. 6A) in Oct-1 was purified from mock- and poliovirus-infected
the SV40 B element activate small nuclear RNA transcrip- extracts as described earlier (Lebowitz et al., 1988). Syn-
tion from the b-globin promoter (Davidson et al., 1986; thetic oligonucleotides with the octamer sequence were
Zenke et al., 1986; Ondek et al., 1987 and 1988). made by Biosynthesis Inc. Forty micrograms of the DNA
Previous reports from our laboratory have shown that containing octamer sequence was attached to CNBr acti-
TBP and initiator-mediated basal transcription is inhib- vated CL-4B Sepharose (Pharmacia). Ten milligrams of
ited soon after infection of host cells by poliovirus nuclear extract was preincubated with 100 mg of poly(dI–
(Kliewer and Dasgupta, 1988; Clark et al., 1993; Yalaman- dC) before loading onto the DNA affinity column equili-
chili et al., 1996). This is mediated primarily by the cleav- brated with buffer Z (25 mM HEPES, pH 7.8, 12.5 mM
age of the transcription factor TBP. We have also shown MgCl2 , 1 mM dithiothreitol (DTT), 20% glycerol, 0.1% Non-recently that the cyclic AMP-responsive element binding idet P-40). The flow through fraction was collected. The
protein (CREB) mediated activated pol II transcription is column was washed with 0.1 M KCl and the eluate was
inhibited in virus-infected cells by proteolytic cleavage discarded. The Oct-1 was eluted from the column with
of the phosphorylated, transcriptionally active form of the 0.4 ml of 1 M KCl. The fraction containing Oct-1 was
CREB protein (Yalamanchili et al., 1997). In this report dialyzed against TM 0.1 buffer and used as the purified
we show that poliovirus infection of HeLa cells leads to Oct-1 in the transcription reactions and Western blot
the cleavage of another transcription activator, Oct-1. analysis. The flow-through fraction was passed over the
This cleavage appears to be mediated by poliovirus pro- octamer column a second time. The second flow-through
tease 3Cpro both in vitro and in vivo. Poliovirus infection fraction was designated Oct-1 depleted extract and used
leads to altered Oct-1–DNA complexes. These altered in transcription reactions.
Oct-1–DNA complexes can be generated in vitro by treat-
ment of nuclear extracts or purified Oct-1 with 3Cpro. Oct- Protease reactions
1 binds to the octamer sequence in the SV40 B enhancer
The poliovirus protease 3CPro was PCR amplified fromand inhibits Sph-mediated transcription from the down-
poliovirus infectious cDNA pT7PV1 and was cloned intostream TATA promoter. Treatment of Oct-1 with 3Cpro (or
pQE30 (Qiagen) in the BamHI and HindIII sites as de-poliovirus infection) results in the loss of the ability of
scribed earlier (Yalamanchili et al., 1996). 3CPro DNA wasOct-1 to inhibit transcriptional activation by the SV40 B
used for transforming Escherichia coli expression cellsenhancer.
M15pRep4 and the plasmid 3CM15pRep4 at an optical
density of 0.7 was induced with 1 mM IPTG (isopropyl
MATERIALS AND METHODS thio galactoside) for 4 h. The histidine-tagged 3Cpro was
purified from induced cells by nondenaturing nickel affin-Cells and viruses
ity chromatography. The indicated amount of 3Cpro was
HeLa cells were grown in spinner culture in minimum incubated with mock-infected extracts or purified Oct-1
essential medium (MEM) (Gibco-BRL) supplemented at 307C for 4 h as previously described (Yalamanchili et
with 6% calf serum, 1 g glucose per liter, and 104 units al., 1996).
per liter penicillin. Cells were infected with poliovirus
Western blot analysistype 1 (Mahoney strain) at a multiplicity of infection of
25, as previously described (Dasgupta, 1983). HeLa cells Proteins were separated by sodium dodecyl sulfate
were also infected with a poliovirus mutant Sel3C-02 at (SDS)–14% polyacrylamide gel electrophoresis (PAGE).
a multiplicity of infection of 25, as previously described The separated proteins were electrophoretically blotted
(Clark et al., 1991). onto nitrocellulose. The nitrocellulose was blocked for 1
h with 1% blocking reagent (Bio-Rad). A mouse mono-
Preparation of extracts clonal antibody against an epitope corresponding to
amino acids 723 to 743 of Oct-1 was used as the primaryNuclear extracts were prepared from mock- and polio-
antibody. The primary antibody was incubated with thevirus-infected HeLa cells as previously described (Dig-
nitrocellulose membrane for 1 h. The secondary antibodynam et al., 1983) with slight modifications. Instead of
was mouse immunoglobulin G coupled to horseradishdialysis against buffer D, the extracts were precipitated
peroxidase. The immunoblot was developed using thewith ammonium sulfate at 50% saturation and the pellet
chemiluminescence detection system (Bio-Rad).was resuspended in TM 0.1 buffer (50 mM Tris, pH 7.4,
12.5 mM MgCl2 , 1 mM EDTA, 1 mM dithiothreitol, 20% Gel shift analysisglycerol, 100 mM KCl) and dialyzed against TM 0.1 buffer
overnight. The extracts were aliquoted and stored at Synthetic double-stranded nucleotides containing the
octamer sequence were end labeled with [g-32P]ATP0707C for further use.
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and T4 polynucleotide kinase. Binding reaction mixtures
(20 ml) contained 25,000 cpm labeled octamer sequence
DNA probe, 10 mM Tris (pH 7.5), 50 mM NaCl, 1 mM
dithiothreitol, 1 mM EDTA, 5% glycerol, and 1 mg of
poly(dI – dC). The reaction mixtures were incubated for
FIG. 1. Modular structure of the transcriptional activator, Oct-1. Three20 min at room temperature. Competition reactions
domains, the N-terminal transcription-activation domain (DI), the DNA-
were performed by including a 100-fold molar excess binding domain (homeodomain) (DII), and the C-terminal domain (DIII)
of nonspecific or specific unlabeled DNA in the binding are shown. The numbers at the bottom indicate positions of amino
reaction. The protein – DNA complexes were separated acids constituting each domain. Numbers at the top indicate potential
glutamine–glycine (Q/G) cleavage sites. The position of Oct-1 (aminoon a 6% polyacrylamide gel (39:1, acrylamide:bisacry-
acids 723–743) shown near the C-terminus was used for preparationlamide) in 0.51 TBE (45 mM Tris, 45 mM boric acid, 1
of antibodies to Oct-1.




Cleavage of Oct-1 in poliovirus infected cells
The SV40 enhancer was PCR amplified from pCAT
vector (Promega) and cloned upstream of the Adenovirus The Oct-1 protein is ubiquitously expressed in many
major late (AdML) TATA-box in the 2038 plasmid (Smale different types of cells. The Oct-1 isolated from HeLa
and Baltimore, 1989; Smale et al., 1990; Zenzie-Gregory cells has an apparent molecular mass of 94 kDa (Sturm
et al., 1993). This plasmid was designated SE2038 (see and Herr, 1988, LeBowitz et al., 1988). To study the tran-
Fig. 6A) and used as a template in the transcription scriptional activator Oct-1 in poliovirus infected cells, cell
assay. Sp1 activated, TATA-mediated transcription was free extracts were prepared from HeLa cells at different
measured using the A126 plasmid described previously times of infection or mock-infection. The extracts were
(Yalamanchili et al., 1996). This plasmid contains an ade- analyzed by Western blot using a rabbit polyclonal anti-
novirus major late promoter TATA-box and 12 Sp1 bind- body against an epitope corresponding to amino acids
ing sites upstream. 723 to 743 of Oct-1 (see Fig. 1). The Oct-1 antibody recog-
nized a protein with an of approximate molecular mass
of 94 kDa in mock-infected extracts (Fig. 2, lane 1). ThisIn vitro transcription assays
was the only protein recognized by the Oct-1 antibody in
mock-infected cell extracts and appears to be the full-The transcription reactions contained 750 ng of
length Oct-1 described earlier (LeBowitz et al., 1988;SE2038 DNA, 40 mg of Oct-1 depleted HeLa nuclear ex-
Sturm and Herr, 1988; Tanaka and Herr, 1992). In poliovi-tract, 2.5 mM (each) ribonucleoside triphosphates
rus infected extracts prepared 3 h postinfection, the Oct-(rNTPs), and 100 U of RNasin and the reaction volume
1 antibody recognized the single 94-kDa full-length Oct-was made up to 50 ml with TM 0.1 buffer. The reaction
1 (Fig. 2, lane 2). However, the antibody recognized twomixtures were incubated at 307C for 90 min and the reac-
bands, the 94-kDa Oct-1 protein and a smaller form oftions were terminated by addition of 90 ml stop solution
Oct-1 that is approximately 55 kDa in extracts prepared(200 mM NaCl, 20 mM EDTA, 1% sodium dodecyl sulfate,
4 h postinfection (Fig. 2, lane 4). The intensity of the full-250 mg of tRNA per milliliter). The RNA was extracted
length Oct-1 was significantly decreased at 4 h postinfec-with phenol–chloroform and ethanol precipitated. The
tion with a concomitant increase in the smaller form ofRNA pellet was dissolved in 10 ml of annealing buffer
Oct-1. However, in mock-infected extracts prepared at 4containing 250 mM NaCl, 5 mM Tris (pH 7.4), 1 mM
h postinfection the 55-kDa truncated form of Oct-1 wasEDTA, and 25,000 cpm of 32P-labeled Sp6 primer. The
not observed (Fig. 2, lane 3). With longer infection timesprimer was annealed to the RNA at 457C for 90 min. The
the amount of full-length Oct-1 decreased further and theannealed mix was analyzed by primer extension in a
amount of the smaller form of Oct-1 increased while therereaction containing 1 mM DTT, reverse transcriptase
was no significant change in the intensity of full-lengthbuffer (50 mM Tris, pH 8.3, 8 mM MgCl2 , 50 mM KCl,
Oct-1 in mock-infected extracts (data not shown). The1.5 mM dNTPs), and 40 U of avian myeloblastosis virus
antibody used for Western analysis recognized an epi-reverse transcriptase (Life Science) in a 20-ml volume.
tope between amino acids 723 and 743 in Oct-1 (Fig. 1).The reactions were incubated at 407C for 90 min and
These amino acids are at the C-terminus end of Oct-1.stopped by the addition of 15 ml stop dye (80% formamide,
Thus, this antibody will pick up only the Oct-1 fragments0.01% xylene cyanol, 0.01% bromophenol blue) and
that contain the C-terminus region. These results suggestloaded onto 8% polyacrylamide–8M urea gels. The gels
that the Oct-1 polypeptide is proteolytically cleaved inwere electrophoresed, dried, and subjected to autoradi-
ography at 0707C. HeLa cells infected with poliovirus.
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nuclear extract was incubated with heat treated 3Cpro,
generation of the smaller product was not apparent (Fig.
3A, lane 6). The size of the cleaved Oct-1 in 3Cpro treated
extracts was identical to that seen in poliovirus-infected
cells (Fig. 3A, compare lanes 2 and 5).
The nuclear extracts used in the above experiment
contain many proteins. It is possible that the 3Cpro acti-
vates a quiescent cellular protease which in turn cleaves
Oct-1. To determine whether 3Cpro can directly cleave
Oct-1, affinity purified Oct-1 and 3Cpro were used in the
in vitro cleavage assay. Oct-1 was purified from HeLa
cells using the DNA affinity purification method (LeBowitz
et al., 1988), whereas recombinant 3Cpro was purified
by nickel affinity chromatography as described earlier
(Yalamanchili et al., 1996). Purified Oct-1 was analyzed
by Western blot analysis and a single 94-kDa band was
visualized (Fig. 3B, lane 3). Incubation of the purified Oct-
1 with purified 3Cpro resulted in the cleavage of Oct-1 to
the smaller 55-kDa product with the disappearance of
full-length Oct-1 (Fig. 3B, lane 4). These results suggest
that Oct-1 is cleaved by the viral protese 3CPro.
Generation of altered Oct-1–DNA complexes by
poliovirus infection
The homeodomain of Oct-1 is absolutely essential forFIG. 2. Western blot analysis of Oct-1 from mock and poliovirus-
infected cell extracts: HeLa cells were mock (M) infected for 3 h (lane binding to the octamer sequence. To determine the do-
1) or 4 h (lane 3) or infected with poliovirus (P) for 3 h (lane 2) or 4 h mains of Oct-1 altered by poliovirus infection, we per-
(lane 4) and cell free nuclear extracts were prepared. These extracts
formed gel retardation assays. Nuclear extracts preparedwere separated on an SDS–14% polyacrylamide gel. The separated
from mock-infected HeLa cells at 3 and 4 h (Fig. 4, lanesproteins were blotted onto nitrocellulose and probed with a rabbit poly-
1 and 3) and poliovirus-infected HeLa cells at 3 and 4 hclonal antibody recognizing an Oct-1 epitope corresponding to amino
acids 723 to 743. Oct-1 was visualized with a chemiluminescence de- postinfection (Fig. 4, lanes 2 and 4) were used in the
tection system. Position of the full-length Oct-1 is indicated by an arrow assay. These extracts were incubated with a labeled
and the position of the cleaved Oct-1 is indicated by an asterisk. The
oligonucleotide containing the consensus octamer se-sizes of the molecular weight markers are shown on left in kilodaltons.
quence. The resultant DNA–protein complexes were re-
solved on a 6% polyacrylamide gel. When mock-infected
Cleavage of Oct-1 by poliovirus-encoded nuclear extracts were used, two complexes were gener-
protease 3Cpro ated, complex I and complex II (Fig. 4, lane 1). Only
complex I could be specifically competed with the coldBecause three other transcription factors, TBP, TFIIIC,
and CREB, are directly cleaved by 3CPro at particular gln– octamer sequence, indicating that complex I was specific
(data not shown). When poliovirus infected extract fromgly sites (Clark et al., 1991 and 1993; Yalamanchili et al.,
1997) and the Oct-1 protein contains four gln–gly sites an early time point of infection (3 h postinfection) was
used in the gel retardation assay, the two complexes(Fig. 1), we determined whether poliovirus encoded prote-
ase, 3Cpro can cleave Oct-1 in vitro. Mock-infected extracts described above were detected (Fig. 4, lane 2). A faint
DNA–protein complex migrating slightly faster than thewere incubated with bacterially expressed and purified
3Cpro at 307 for 4 h. The treated extracts were separated complex I could also be detected (lane 2). The intensity
of the third complex increased significantly when nuclearon SDS–polyacrylamide gel and blotted onto nitrocellu-
lose. The blot was probed with an antibody against Oct- extract from poliovirus-infected cells at 4 h postinfection
was used in the DNA-binding assay (Fig. 4, lane 4). The1. As expected, untreated mock-infected extracts showed
the presence of the 94-kDa Oct-1 protein (Fig. 3A, lane 3). appearance of the third complex correlated with the ap-
pearance of the cleaved 55-kDa Oct-1 product in poliovi-When HeLa cell nuclear extracts were treated with 4 mg
of 3Cpro, Oct-1 was found to be cleaved into the smaller rus infected extracts (compare Figs. 2 and 4). HeLa cells
were also infected with the poliovirus mutant, Sel-3C02.55-kDa protein (Fig. 3A, lane 5). Although incubation of
extracts with 1 mg of 3Cpro resulted in significant decrease This mutant virus contains a single amino acid substitu-
tion within the 3C protease gene (Dewalt and Semler,in full-length Oct-1, we were unable to detect the cleaved
product for unknown reasons (Fig. 3A, lane 4). When the 1987). The resulting virus displays a small plaque pheno-
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FIG. 3. Western blot analysis of Oct-1 treated with 3Cpro. (A) Western blot analysis of mock-infected nuclear extracts treated with 3Cpro. Mock-
infected nuclear extracts (M) were incubated with 0.1, 1, and 4 mg 3Cpro (lanes 3, 4, 5, respectively) or 4 mg of heat treated 3Cpro (lane 6) at 307C
for 4 h. Treated extracts were separated on an SDS–polyacrylamide gel and analyzed as described above. Mock-infected and poliovirus-infected
extracts prepared 3 h postinfection were also run on the same gel (lanes 1 and 2, respectively). Position of the full length Oct-1 is indicated by an
arrow and that of cleaved Oct-1 is indicated by a star. The sizes of the molecular weight markers are on the left in kilodaltons. (B) Western blot
analysis of purified Oct-1 treated with recombinant, purified 3Cpro. Oct-1 was purified from HeLa cell extracts by DNA affinity chromatography as
described under Material and Methods. Purified Oct-1 was treated with buffer (lane 3) or 4 mg of 3Cpro (lane 4). Lanes 1 and 2 show Western
analysis of mock-infected or poliovirus infected extracts prepared 3 h postinfection. The position of full-length Oct-1 is indicated by an arrow and
that of cleaved Oct-1 is indicated by an asterisk.
type and is characterized by having a reduced 3Cpro activ- complex was observed (Fig. 5A, lanes 4 and 5). This
complex migrated at the same position as complex IIIity. We have shown previously that this mutant virus is
seen in poliovirus infected cells (Fig. 5A, compare lanesdefective in shutting off host cell transcription compared
4 and 5 with lane 2). The low amount of complex IIIto the wild type virus (Clark et al., 1991; Yalamanchili et
detected in the virus-infected extract was due to the factal., 1996). Nuclear extracts were prepared from Sel-3C02
that these cells were infected for only 3 h (Fig. 5A, lane 2).infected cells 4 h postinfection and used for gel retarda-
A greater amount of complex III is observed in poliovirustion analysis. In these extracts only complex I and com-
infected extracts prepared 4 h postinfection (Fig. 4, laneplex II were detected (Fig. 4, lane 5). Complex III could not
4). Treatment with increasing concentrations of 3Cpro re-be detected in this reaction, indicating that 3Cpro might be
sulted in a decrease in the amount of complex I andinvolved in the generation of complex III seen in cells
increase in the amount of complex III (Fig. 5A, lanes 3infected with the wild type poliovirus.
to 5). Complex III was not generated when mock extracts
were treated with a purified, mutant 3Cpro whose active3Cpro generates Oct-1-DNA complex III in vitro
site cysteine 147 was changed to a serine (Fig. 5A, lane
To determine the alterations of Oct-1 in 3Cpro treated 6). Earlier studies showed that truncated versions of Oct-
extracts, gel retardation analysis was used. The probe 1 form DNA–protein complexes that migrate faster than
and the assay were identical to that described above. the full-length Oct-1–DNA complex. These results sug-
HeLa nuclear extracts were treated with increasing con- gest that complex III might be composed of cleaved Oct-
centrations of purified 3Cpro. The treated extracts were 1. To further confirm that complex I and complex III are
then incubated with the labeled octamer probe. Only composed of Oct-1, purified Oct-1 was used in the gel
complexes I and II were detected in untreated mock- shift assay. Affinity purified Oct-1 formed a single DNA–
infected extracts (Fig. 5A, lane 1). When mock-infected protein complex that migrated with complex I from mock-
infected cells, confirming that complex I contains Oct-1extract was treated with 3Cpro an additional DNA–Oct-1
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lower Sph-mediated transcription from the downstream
promoter. Thus, Sph and Oct-1 compete with each other
for binding to their respective sites. To determine
whether 3Cpro treatment and poliovirus infection alter the
ability of Oct-1 to inhibit Sph-mediated transcription from
the SV40 enhancer, it was necessary to purify Oct-1 from
HeLa cells and generate HeLa nuclear extracts depleted
of Oct-1. Oct-1 depleted extracts were generated by
passing HeLa extracts through a DNA affinity column
containing the octamer sequence. The bound Oct-1 was
eluted using a buffer containing high salt which was then
dialyzed against a buffer containing low salt concentra-
tion. Purified Oct-1 was used to study the effect of Oct-
1 on transcription from a plasmid containing the adenovi-
rus major late promoter TATA-box and SV40 B enhancer
(SE2038, Fig. 6A). The RNA synthesized in vitro was ex-
amined using primer extension analysis as described
under Materials and Methods. Nuclear extracts depleted
of Oct-1 supported Sph-activated transcription from the
pSE2038 (Fig. 6B, lane 1). Addition of purified Oct-1 de-
rived from mock-infected cells reduced transcription from
pSE2038 by 75% compared to that seen with the control
(Fig. 6B, compare lane 2 with lane 1). Because basal
transcription from a promoter containing only the TATAFIG. 4. Gel retardation analysis of Oct-1 from mock (M)- and poliovi-
box (lacking Oct-1 or any other activator) is extremelyrus (P)-infected cell extracts. Gel retardation assays were performed
with mock-infected cell extracts prepared 3 and 4 h postinfection (lanes low, control transcription reactions were performed in
1 and 3, respectively), poliovirus-infected extracts prepared 3 and 4 h which the Oct-1 site was replaced by Sp1 site in the
postinfection (lanes 2 and 4, respectively), and poliovirus mutant Sel- plasmid SE 2038. The resulting plasmid (termed A126)
3C02-infected extracts prepared 4 h postinfection (lane 5). An oligonu-
support Sp1 activated TATA-mediated transcription (Ya-cleotide with the octamer consensus sequence ATGCAAAT was radio-
lamanchili et al., 1996). Addition of Oct-1 to Oct-1 de-labeled with [g-32P]ATP and used as the probe. The Oct-1–DNA com-
plexes were separated on a native 6% polyacrylamide gel. DNA–protein pleted extracts supporting Sp1 activated transcription
complexes I, II, and III are indicated to the right. from the A126 plasmid did not cause a decrease in tran-
scription, indicating that only Sph-1 but not Sp1-activated
transcription was inhibited by Oct-1 (Fig. 6C, lanes 1 and
and complex II seen in mock-infected extracts is nonspe- 2). Addition of Oct-1 purified from poliovirus infected cells
cific (Fig. 5B, lane 1). When Oct-1 was purified from polio- did not inhibit transcription significantly from pSE2038;
virus-infected cells two complexes migrating with com- transcription was reduced by only 25% compared to that
plex I and complex III were detected (Fig. 5B, lane 2). seen in the control (Fig. 6B, compare lane 3 with lane 1).
Treatment of mock-infected cell-derived, purified Oct-1 To determine the role of 3Cpro cleavage, purified Oct-1
with 3Cpro resulted in the formation of complex III with a was treated with 3Cpro prior to its addition to the transcrip-
concomitant decrease of complex I (Fig. 5B, lanes 3 to tion reaction. Oct-1 treated with 3Cpro could no longer
5). However, an enzymatically inactive, mutant 3Cpro was inhibit transcription from pSE2038 (Fig. 6B, lane 4). Figure
unable to generate complex III (Fig. 5B, lane 6). These 7 shows titration of Oct-1 in transcription reactions pro-
results strongly suggest that the complex III form of Oct- grammed by the plasmid SE2038. As is evident from Fig.
1 is generated by 3Cpro in virus infected cells. 7A, Sph-mediated transcription is inhibited in an Oct-1
dose dependent manner (lanes 1–4). The inhibition of3Cpro inhibits Oct-1 activity
transcription caused by Oct-1 is fully restored by prior
treatment of purified Oct-1 with 3Cpro (Fig. 7B, compareSV40 enhancer B element has an octamer binding mo-
tif formed by the junction of the two Sph motifs (Fig. 6A). lane 2 and 3 with lane 1). These results suggest that
Oct-1, when isolated from poliovirus-infected cells orBinding of Sph to its binding sites results in the activation
of transcription from the TATA element present down- treated with 3Cpro, loses its ability to interfere with Sph-
mediated transcription from the SE2038 plasmid. Itstream in HeLa cells. Binding of Oct-1 to the octamer
site excludes the binding of Sph to its sites and interferes should be noted that Oct-1 is not purified away from
3Cpro before it is added to the transcription reactions.with transcriptional activation by Sph. Since Oct-1 does
not activate transcription from the TATA-box in HeLa Under this condition, TBP is not cleaved since 3Cpro is
diluted 10-fold during transcription reactions. Moreover,cells, binding of Oct-1 to the SV40 enhancer results in
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FIG. 5. Gel retardation analysis of Oct-1 treated with 3Cpro. (A) Gel retardation analysis of Oct-1 in mock-infected extracts treated with 3Cpro.
Mock-infected (M) extracts were treated with 0.1, 0.4, and 2 mg of 3Cpro (lanes 3, 4, 5, respectively) or with 2 mg of an enzymatically inactive mutant
(C147S) 3CPro (lane 6). The treated extracts were used in the gel retardation assay with the octamer consensus sequence as the probe. Untreated
mock-infected extracts and poliovirus-infected extracts are also shown (lanes 1 and 2, respectively). (B) Gel retardation analysis of purified Oct-1
treated with 3Cpro. Oct-1 was purified from mock- or poliovirus-infected cell extracts by DNA affinity chromatography. Purified Oct-1 from mock-
infected (lane 1) or poliovirus infected cells (lane 2) was used in the gel retardation assay. Purified Oct-1 from mock-infected cells was treated with
0.1, 0.4, and 2 mg 3Cpro (lanes 3, 4, 5, respectively) or with 4 mg of mutant 3Cpro (lane 6). FP, free probe.
TBP cleavage is slow (3 –4 h) relative to transcription transcription mediated by the SV40 B element. These re-
sults suggest that poliovirus-encoded protease 3CProreactions (1 h).
cleaves and inactives the transcriptional activator, Oct-1.
The Oct-1 protein is modular and contains three dis-DISCUSSION
tinct domains (Fig. 1). The N-terminal domain is essential
In this report we provide evidence suggesting that the for activation of transcription. It extends from amino acid
transcriptional activator protein, Oct-1, is cleaved in HeLa 1 to amino acid 280. The homeodomain from amino acid
cells infected with poliovirus. First, in virus-infected cells 280 to amino acid 440 is essential for DNA binding. The
there was a significant decrease in full-length Oct-1 with C-terminal domain extends from amino acid 440 to amino
a concomitant increase of a 55-kDa cleaved form of Oct- acid 766. The antibody used in the Western analysis
1. Second, Oct-1 in mock-infected HeLa cell extract as recognized an epitope between amino acid 723 and
well as purified Oct-1 can be converted into the cleaved amino acid 743 within the C terminus of Oct-1 (Fig. 1).
form by treatment with recombinant, purified 3CPro. Third, Thus, the cleaved form of Oct-1 recognized by the anti-
upon poliovirus infection, a new faster migrating Oct-1– body in poliovirus infected extracts must contain these
Octamer complex is formed compared to the complex amino acids. Moreover, the cleaved Oct-1 probably binds
seen in uninfected (or mock-infected) cells. Treatment of DNA to form complex III, suggesting that it must also
purified Oct-1 with 3CPro leads to the formation of a com- contain a functionally intact homeodomain. Thus the 55-
plex similar to that observed in virus-infected cell extracts. kDa cleaved Oct-1 seen in poliovirus infected cell ex-
Finally, Oct-1 from poliovirus-infected cells or purified Oct- tracts must have an N-terminus deletion. Since the N-
terminus is essential for activated transcription, the1 treated with 3CPro loses its ability to inhibit activated
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FIG. 7. Inhibition of Sph-activated transcription by various concentra-
tions of Oct-1. (A) Forty micrograms of Oct-1 depleted HeLa cell extract
was used for in vitro transcription analysis using the SE2038 plasmid in
the absence (lane 1) or presence of 0.25 (lane 2), 0.5 (lane 3), and 1 (lane
4) mg of purified Oct-1. (B) Transcription from pSE2038 was analyzed in
the absence (lane 1) or presence of 1 mg untreated Oct 1 (lane 2) or 1
mg of Oct-1 pretreated with 0.4 (lane 3) and 2 (lane 4) mg of 3Cpro.
cleaved Oct-1 would no longer support activated tran-
scription. The molecular weight of the cleaved product
is consistent with the cleavage at position 330 (gln/gly)
of Oct-1 as the antibody to the C-terminal peptide of Oct-
1 reacts with the 55-kDa 3Cpro cleaved product in the
Western blot. Whether the other glutamine–glycine sites
are also cleaved by 3Cpro is not known. Future studies
involving site directed mutagenesis of individual gln/gly
sites will allow determination of the precise 3Cpro cleav-
age site(s) on Oct-1.
Oct-1 activates some of the most heavily transcribed
small nuclear RNA genes. We did not address the effect
of 3Cpro on Oct-1 activated snRNA transcription for two
reasons. First, 3Cpro inhibits basal transcription in cells
by cleaving TBP (TATA binding protein) and any inhibition
FIG. 6. (A) SE 2038 plasmid. The SV40 enhancer was cloned up- of Oct-1 activated transcription seen in vivo could be due
stream of the adenovirus major late promoter TATA-box. The transcrip- to the inhibition of basal transcription caused by TBP
tion start site is indicated by an arrow. The nucleotide sequence of the cleavage. Thus, we cannot specifically address the inhi-
B element and the Sph-binding sites I and II are indicated. The octamer-
bition of Oct-1 activated transcription in vivo. Second, thebinding motif (ATGCAAAG) overlaps with Sph II and Sph I binding sites.
homeodomain (DNA-binding domain) of Oct-1 activatesThe binding of Oct-1 to the octamer binding site interferes with Sph
snRNA transcription in vitro, while the N-terminus of Oct-binding and inhibits Sph-mediated transcription from the upstream
TATA promoter. (B) In vitro transcriptional analysis of Oct-1 purified 1 activates snRNA transcription in vivo (Hernandez and
from mock- and poliovirus-infected cells or Oct-1 treated with 3Cpro. Lucito, 1988; Ondek et al., 1987; Sturm and Herr, 1988).
Forty micrograms of Oct-1 depleted HeLa cell extract was used for in Therefore, the results we obtain in vitro might not reflect
vitro transcription analysis using the SE2038 plasmid and the resultant the in vivo effect. To study the activity of Oct-1 in infected
transcript was examined by primer extension analysis using g-32P-
cells we used the SV40 B enhancer. Oct-1 and Sph havelabeled primer. The position of the correctly initiated transcript is indi-
overlapping binding sites in the SV40 B enhancer. Sphcated by an arrow. Oct-1 depleted extracts were supplemented with
activates transcription from the downstream TATA pro-buffer alone (lane 1) or 1 mg of Oct-1 purified from mock (M)-infected
cells (lane 2) or poliovirus-infected cells (lane 3) and 1 mg of purified moter while Oct-1 does not activate transcription from
Oct-1 from mock (M)-infected cells treated with 2 mg of 3Cpro (lane 4). the TATA promoter. Binding of Oct-1 to its site in the
(C) Forty micrograms of Oct-1 depleted HeLa cell extract was used for SV40 B enhancer excludes Sph from its sites and results
in vitro transcription using the A126 plasmid and the resultant transcript
in lower Sph-mediated transcription. Our results showwas examined by primer extension analysis. TATA-box mediated, Sp1
that Oct-1 from poliovirus-infected cells or Oct-1 treatedactivated transcription was measured from the A126 plasmid in the
with 3Cpro cannot inhibit Sph-mediated transcription effi-presence of buffer alone (lane 1) or 1 mg of Oct-1 purified from mock-
infected cells. ciently from the SV40 B enhancer although cleaved Oct-
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07323 and GM-07104 from the National Institutes of Health. We are1 still binds to the Octamer sequence as revealed by gel
grateful to E. Berlin for excellent secretarial assistance.retardation analysis. This could be due to two reasons:
either cleaved Oct-1 does not bind DNA as effectively
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